Research is closed to new participants.
No new participates are being accepted at this time for current product evaluation. Research Group Size has been reached and registration is closed.
Only those participants currently registered may continue to access products online.
The NeriumDerm Study evaluation is in process.
The NeriumCS Study is completed and is moving to next appropriate step in clinical research.
Invitation to Participate in Continuing Skin Product Research
Nerium SkinCare extends to our Nerium Shareholders the opportunity to participate in on-going specialized product clinical research in concert with Science, Toxicology and Technology (ST&T) and the opportunity to experience our new skin care products first-hand. In so doing, you will help Nerium SkinCare gain market experience with its new skin care products. Your participation is important to Nerium Skincare and will be much appreciated.
Nerium Skincare's parent company Nerium Biotechnology, Inc. (NBI) has focused its research and development on anti-cancer, anti-viral, immune-stimulating, and skin properties/applications of its botanical compounds. This core research has been performed in concert with leading medical research institutions in the United States. The next strategic move is to harness what we have learned over the past 10 years from the research of the Nerium oleander plant extracts and apply it to the cosmetic skin care market—a market expected to grow significantly.